Recall: Anagrelide
Jun. 2022Pharmacy Updates
Teva has recalled one lot of Anagrelide 0.5 mg capsules. Anagrelide is used to treat conditions that cause a patient’s platelet count to be too high. The drug is being recalled because testing showed that it took longer than expected for the medication to dissolve in the body. Read the full text of the Anagrelide recall.
Recent Announcements
UPMC Health Plan Tapestry Link resources available
UPMC Health Plan Tapestry Link will launch on Tuesday, Dec. 1, 2026. To help ease your transition to the new platform, we have developed the following resources:Nov. 2026Important Notices
Changes to inpatient denial and OBS claim billing
We will soon transition to the Epic® platform. This change will align our claims processing with industry standards by adjudicating claims based on the level of care authorized. As this transition approaches, please keep the following areas in mind:Nov. 2026
Provider Services does not accept automated calls
Provider Services does not accept automated callsNov. 2026Important Notices